{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:59:26Z","timestamp":1790189966769,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) is associated with an elevated risk of cardiovascular disease and necessitates repeat revascularization procedures, including percutaneous coronary intervention (PCI). However, extensive data on outcomes following PCI in this cohort remain scarce. This systematic review and meta-analysis sought to evaluate the short- and long-term cardiovascular outcomes in RA patients following PCI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a search of PubMed, Embase, Google Scholar, and Cochrane Central for studies published until October 2024 that compared RA and non-RA cohorts\u2019 post-PCI. The primary outcomes encompassed major adverse cardiovascular events, myocardial infarction, repeat revascularization, and overall mortality. The pooled odds ratio (OR) with 95% confidence intervals was computed utilizing random-effects models. A sensitivity analysis was conducted using a leave-one-out meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Our search identified 9 qualifying studies, encompassing nearly 1 million patients (174,229 with RA and 9771,911 without RA). Individuals with RA exhibited a markedly elevated risk of short-term stroke compared to non-RA patients (OR: 0.81, 95% CI: 0.6\u20131.02). Long-term follow-up found an elevated risk of myocardial infarction (OR: 1.08, 95% CI: 1.01\u20131.16), stroke (OR: 1.09, 95% CI: 1.07\u20131.11), major adverse cardiovascular events (OR: 1.12, 95% CI: 0.99\u20131.24), and repeat revascularization (OR: 1.09, 95% CI: 1.07\u20131.11) among patients with RA. The sensitivity analysis revealed no significant difference, even after the exclusion of each study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This comprehensive meta-analysis revealed that patients with RA have markedly poorer clinical outcomes post-PCI, particularly in the long term. The results underline the necessity for tailored peri-procedural approaches and ongoing monitoring in RA patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000044458","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:00:28Z","timestamp":1757970028000},"page":"e44458","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Short-term and long-term outcomes in rheumatoid arthritis patients following percutaneous coronary intervention: A systematic review and meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Sulochana","family":"Khadka","sequence":"first","affiliation":[{"name":"Department of Medicine, UPMC Harrisburg, Harrisburg, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibek","family":"Timilsina","sequence":"additional","affiliation":[{"name":"Department of Medicine, Virtua Our lady of Lourdes Hospital, Camden, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshata","family":"Ammembal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kasturba Medical College, Manipal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6961-0822","authenticated-orcid":false,"given":"Faisal","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Chittagong Medical College Hospital, Chattogram, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karun","family":"Suwal","sequence":"additional","affiliation":[{"name":"Department of Orthodontics, Nepal Medical College, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibek","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishow Nath","family":"Adhikari","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kanti Children\u2019s Hospital, Maharajgunj, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimarsh","family":"Acharya","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kist Medical College and Teaching Hospital, Lalitpur, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabin","family":"Baniya","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nepal Medical College and Teaching Hospital, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Gyawali","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Tribhuvan University Teaching Hospital, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali Kumari","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Hospital Administration, Chitwan Medical College, Chitwan, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosna","family":"Thapa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Nepal Cancer Hospital and Research Center. Lalitpur, Nepal."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260923","doi-asserted-by":"crossref","first-page":"1051082","DOI":"10.3389\/fimmu.2022.1051082","article-title":"Systemic complications of rheumatoid arthritis: focus on pathogenesis and treatment.","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"R2-20260923","doi-asserted-by":"crossref","first-page":"k1036","DOI":"10.1136\/bmj.k1036","article-title":"Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications.","volume":"361","author":"England","year":"2018","journal-title":"BMJ"},{"key":"R3-20260923","doi-asserted-by":"crossref","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","article-title":"Rheumatoid arthritis: extra-articular manifestations and comorbidities.","volume":"20","author":"Figus","year":"2021","journal-title":"Autoimmun Rev"},{"key":"R4-20260923","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.24836","article-title":"Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.","volume":"61","author":"Peters","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R5-20260923","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/CRD.0000000000000486","article-title":"Cardiovascular manifestations in rheumatoid arthritis.","volume":"32","author":"Sanghavi","year":"2024","journal-title":"Cardiol Rev"},{"key":"R6-20260923","first-page":"1042","article-title":"Ischemic heart disease and rheumatoid arthritis \u2013 two conditions, the same background.","volume":"11","author":"Rezu\u0219","year":"2021","journal-title":"Life (Basel)"},{"key":"R7-20260923","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10067-014-2695-y","article-title":"The impact of inflammatory rheumatic diseases on the presentation, severity, and outcome of acute coronary syndrome.","volume":"35","author":"Ben-Zvi","year":"2016","journal-title":"Clin Rheumatol"},{"key":"R8-20260923","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3899\/jrheum.120941","article-title":"Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis.","volume":"40","author":"McCoy","year":"2013","journal-title":"J Rheumatol"},{"key":"R9-20260923","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1002\/art.20556","article-title":"Outcomes of hospitalizations for myocardial infarctions and cerebrovascular accidents in patients with systemic lupus erythematosus.","volume":"50","author":"Ward","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R10-20260923","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.mpmed.2022.04.008","article-title":"Percutaneous coronary intervention.","volume":"50","author":"Khan","year":"2022","journal-title":"Medicine (Baltim)"},{"key":"R11-20260923","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/annrheumdis-2015-207719","article-title":"Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study.","volume":"75","author":"Lai","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R12-20260923","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R13-20260923","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","article-title":"Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review.","volume":"21","author":"Bosco","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"R15-20260923","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"key":"R17-20260923","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjcard.2020.10.048","article-title":"Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis.","volume":"140","author":"Dawson","year":"2021","journal-title":"Am J Cardiol"},{"key":"R18-20260923","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jtcvs.2009.09.036","article-title":"Mortality after coronary artery revascularization of patients with rheumatoid arthritis.","volume":"140","author":"Varghese","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R19-20260923","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3390\/healthcare11101381","article-title":"Outcomes of percutaneous coronary intervention in elderly patients with rheumatoid arthritis: a nationwide population-based cohort study.","volume":"11","author":"Kim","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"R20-20260923","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1093\/rheumatology\/kez639","article-title":"Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.","volume":"59","author":"Martinez","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R21-20260923","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.amjcard.2011.11.056","article-title":"Outcomes of nonstenting percutaneous coronary intervention in patients with rheumatoid arthritis.","volume":"109","author":"Kang","year":"2012","journal-title":"Am J Cardiol"},{"key":"R22-20260923","doi-asserted-by":"crossref","first-page":"e0281067","DOI":"10.1371\/journal.pone.0281067","article-title":"Clinical outcomes of patients with rheumatoid arthritis who underwent percutaneous coronary intervention: a Korean nationwide cohort study.","volume":"18","author":"Ha","year":"2023","journal-title":"PLoS One"},{"key":"R23-20260923","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijcard.2019.12.055","article-title":"Outcomes of percutaneous coronary intervention (PCI) among patients with connective tissue disease: propensity match analysis.","volume":"304","author":"Alliu","year":"2020","journal-title":"Int J Cardiol"},{"key":"R24-20260923","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.carrev.2024.02.020","article-title":"In-hospital outcomes and trends of patients with autoimmune diseases undergoing percutaneous coronary intervention: a nationwide analysis.","volume":"65","author":"Antia","year":"2024","journal-title":"Cardiovasc Revasc Med"},{"key":"R25-20260923","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R26-20260923","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/annrheumdis-2020-217154","article-title":"Impact of rheumatoid arthritis on major cardiovascular events in patients with and without coronary artery disease.","volume":"79","author":"L\u00f8gstrup","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R27-20260923","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R28-20260923","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update.","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R29-20260923","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","article-title":"Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.","volume":"359","author":"Choi","year":"2002","journal-title":"Lancet"},{"key":"R30-20260923","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:00:39Z","timestamp":1790186439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":28,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044458","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}